Jin, X.
Hummel, Y. M.
Tay, W. T.
Nauta, J. F.
Bamadhaj, N. S. S.
van Melle, J. P.
Lam, C. S. P.
Voors, A. A.
Hoendermis, E. S.
Article History
Accepted: 25 January 2021
First Online: 16 February 2021
Conflict of interest
: C.S.P. Lam is supported by a Clinician Scientist Award from the National Medical Research Council of Singapore; has received research support from Boston Scientific, Bayer, Roche Diagnostics, AstraZeneca, Medtronic, and Vifor Pharma; has served as consultant or on the Advisory Board/Steering Committee/Executive Committee for Abbott Diagnostics, Amgen, Applied Therapeutics, AstraZeneca, Bayer, Biofourmis, Boehringer Ingelheim, Boston Scientific, Corvia Medical, Cytokinetics, Darma Inc., Us2.ai, JanaCare, Janssen Research & Development LLC, Medtronic, Menarini Group, Merck, MyoKardia, Novartis, Novo Nordisk, Radcliffe Group Ltd., Roche Diagnostics, Sanofi, Stealth BioTherapeutics, The Corpus, Vifor Pharma and WebMD Global LLC; and serves as co-founder & non-executive director of Us2.ai. X. Jin, Y.M. Hummel, W.T. Tay, J.F. Nauta, N.S.S. Bamadhaj, J.P. van Melle, A.A. Voors and E.S. Hoendermis declare that they have no competing interests.